Gregory Anderson, DPM
Foot & Ankle Surgery · Salt Lake City, UTNPI 1992797492
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $1,581,248 of the $1,617,055 with a category attached, or 97.8%. Stryker accounts for 97.9% of it on its own, with 12 other manufacturers making up the rest. Among foot & ankle surgery clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 115 payments — averaging $14,061 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1.6M
- Heron Therapeutics, Inc.$31K
- Treace Medical Concepts, Inc.$2K
- Anika Therapeutics, Inc.$530
- Integra Lifesciences Corporation$468
- Medshape, Inc.$58
- plus $235 from 7 others
What the payments were for
- Royalty or licence$1,581,24898%
- Consulting fees$1,5750%
- Speaking & faculty fees$23,0561%
- Travel & lodging$9,4511%
- Food & beverage$1,1720%
- Education$1350%
- Other$4190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 59 | $1,583,254 |
| Heron Therapeutics, Inc. | 32 | $30,586 |
| Treace Medical Concepts, Inc. | 6 | $1,925 |
| Anika Therapeutics, Inc. | 3 | $530 |
| Integra Lifesciences Corporation | 5 | $468 |
| Medshape, Inc. | 1 | $58 |
| Biotronik NRO, Inc. | 1 | $58 |
| Medtronic | 3 | $53 |
| Trilliant Surgical LLC. | 1 | $41 |
| Fusion Orthopedics USA, LLC | 1 | $32 |
| Biocomposites Inc | 1 | $22 |
| Mimedx Group, Inc. | 1 | $17 |
| Nevro Corp. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PHALINX$1,555,786
- Zynrelef$30,455
- ORTHOLOC$16,427
- TCP$5,988
- ORTHOLOC 3DI$3,048
- MAKO$1,751
- LAPIPLASTY SYSTEM 1$977
- Lapiplasty System$759
- TACTOSET$496
- ACell$419
- PROPHECY$135
How this compares
$1,617,055 in reported general payments places this provider in the 95th percentile of 104 foot & ankle surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $314 |
| Methylprednisolone | 26 | $169 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $145 |
| Cephalexin | 11 | $91 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Salt Lake City
- Florian NickischSalt Lake City$474K
- Brian LiljenquistSalt Lake City$263K
- Douglas TooleSalt Lake City$258K
- David SeegmillerSalt Lake City$120K
- Grant SunSalt Lake City$11K
- Amanda KhourySalt Lake City$10K
- Callie MorlockSalt Lake City$9K
- Jordan ButterfieldSalt Lake City$7K
- Daniel PreeceSalt Lake City$7K
- Christopher FunkSalt Lake City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.